The global Rabies Vaccine market is projected to grow from US$ 971.4 million in 2024 to US$ 1229.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.0% during the forecast period.

Rabies Vaccine Market

Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.

Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.

China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.

In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.

Report Covers:

This report presents an overview of global market for Rabies Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Rabies Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Rabies Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Rabies Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Rabies Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Rabies Vaccine sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Rabies Vaccine Market Report

Report Metric	Details
Report Name	Rabies Vaccine Market
Accounted market size in 2024	US$ 971.4 million
Forecasted market size in 2030	US$ 1229.1 million
CAGR	4.0
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Vero Cell Rabies Vaccine BHK Chick Embryo Cell Rabies Vaccine Others
Segment by Application	Pre-exposure Prophylaxis Post-exposure Prophylaxis
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Chengda, Yisheng, Prcmise, VACN, Changsheng, BCHT, Hissen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Rabies Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Rabies Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rabies Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Rabies Vaccine Market growing?

Ans: The Rabies Vaccine Market witnessing a CAGR of 4.0 during the forecast period 2024-2030.

What is the Rabies Vaccine Market size in 2030?

Ans: The Rabies Vaccine Market size in 2030 will be US$ 1229.1 million.

What is the market share of major companies in Rabies Vaccine Market?

Ans: Global top four manufacturers hold a share about 70%.

What is the Rabies Vaccine Market share by type?

Ans: In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%.

Who are the main players in the Rabies Vaccine Market report?

Ans: The main players in the Rabies Vaccine Market are Chengda, Yisheng, Prcmise, VACN, Changsheng, BCHT, Hissen

What are the Application segmentation covered in the Rabies Vaccine Market report?

Ans: The Applications covered in the Rabies Vaccine Market report are Pre-exposure Prophylaxis, Post-exposure Prophylaxis

What are the Type segmentation covered in the Rabies Vaccine Market report?

Ans: The Types covered in the Rabies Vaccine Market report are Vero Cell Rabies Vaccine, BHK, Chick Embryo Cell Rabies Vaccine, Others

1 Study Coverage

1.1 Rabies Vaccine Product Introduction

1.2 Market by Type

1.2.1 Global Rabies Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Vero Cell Rabies Vaccine

1.2.3 BHK

1.2.4 Chick Embryo Cell Rabies Vaccine

1.2.5 Others

1.3 Market by Application

1.3.1 Global Rabies Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Pre-exposure Prophylaxis

1.3.3 Post-exposure Prophylaxis

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Rabies Vaccine Sales Estimates and Forecasts 2019-2030

2.2 Global Rabies Vaccine Revenue by Region

2.2.1 Global Rabies Vaccine Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Rabies Vaccine Revenue by Region (2019-2024)

2.2.3 Global Rabies Vaccine Revenue by Region (2025-2030)

2.2.4 Global Rabies Vaccine Revenue Market Share by Region (2019-2030)

2.3 Global Rabies Vaccine Sales Estimates and Forecasts 2019-2030

2.4 Global Rabies Vaccine Sales by Region

2.4.1 Global Rabies Vaccine Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Rabies Vaccine Sales by Region (2019-2024)

2.4.3 Global Rabies Vaccine Sales by Region (2025-2030)

2.4.4 Global Rabies Vaccine Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Rabies Vaccine Sales by Manufacturers

3.1.1 Global Rabies Vaccine Sales by Manufacturers (2019-2024)

3.1.2 Global Rabies Vaccine Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rabies Vaccine in 2023

3.2 Global Rabies Vaccine Revenue by Manufacturers

3.2.1 Global Rabies Vaccine Revenue by Manufacturers (2019-2024)

3.2.2 Global Rabies Vaccine Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Rabies Vaccine Revenue in 2023

3.3 Global Key Players of Rabies Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Rabies Vaccine Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Rabies Vaccine, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Rabies Vaccine, Product Offered and Application

3.8 Global Key Manufacturers of Rabies Vaccine, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Rabies Vaccine Sales by Type

4.1.1 Global Rabies Vaccine Historical Sales by Type (2019-2024)

4.1.2 Global Rabies Vaccine Forecasted Sales by Type (2025-2030)

4.1.3 Global Rabies Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Rabies Vaccine Revenue by Type

4.2.1 Global Rabies Vaccine Historical Revenue by Type (2019-2024)

4.2.2 Global Rabies Vaccine Forecasted Revenue by Type (2025-2030)

4.2.3 Global Rabies Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Rabies Vaccine Price by Type

4.3.1 Global Rabies Vaccine Price by Type (2019-2024)

4.3.2 Global Rabies Vaccine Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Rabies Vaccine Sales by Application

5.1.1 Global Rabies Vaccine Historical Sales by Application (2019-2024)

5.1.2 Global Rabies Vaccine Forecasted Sales by Application (2025-2030)

5.1.3 Global Rabies Vaccine Sales Market Share by Application (2019-2030)

5.2 Global Rabies Vaccine Revenue by Application

5.2.1 Global Rabies Vaccine Historical Revenue by Application (2019-2024)

5.2.2 Global Rabies Vaccine Forecasted Revenue by Application (2025-2030)

5.2.3 Global Rabies Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global Rabies Vaccine Price by Application

5.3.1 Global Rabies Vaccine Price by Application (2019-2024)

5.3.2 Global Rabies Vaccine Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Rabies Vaccine Market Size by Type

6.1.1 US & Canada Rabies Vaccine Sales by Type (2019-2030)

6.1.2 US & Canada Rabies Vaccine Revenue by Type (2019-2030)

6.2 US & Canada Rabies Vaccine Market Size by Application

6.2.1 US & Canada Rabies Vaccine Sales by Application (2019-2030)

6.2.2 US & Canada Rabies Vaccine Revenue by Application (2019-2030)

6.3 US & Canada Rabies Vaccine Market Size by Country

6.3.1 US & Canada Rabies Vaccine Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Rabies Vaccine Sales by Country (2019-2030)

6.3.3 US & Canada Rabies Vaccine Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Rabies Vaccine Market Size by Type

7.1.1 Europe Rabies Vaccine Sales by Type (2019-2030)

7.1.2 Europe Rabies Vaccine Revenue by Type (2019-2030)

7.2 Europe Rabies Vaccine Market Size by Application

7.2.1 Europe Rabies Vaccine Sales by Application (2019-2030)

7.2.2 Europe Rabies Vaccine Revenue by Application (2019-2030)

7.3 Europe Rabies Vaccine Market Size by Country

7.3.1 Europe Rabies Vaccine Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Rabies Vaccine Sales by Country (2019-2030)

7.3.3 Europe Rabies Vaccine Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Rabies Vaccine Market Size

8.1.1 China Rabies Vaccine Sales (2019-2030)

8.1.2 China Rabies Vaccine Revenue (2019-2030)

8.2 China Rabies Vaccine Market Size by Application

8.2.1 China Rabies Vaccine Sales by Application (2019-2030)

8.2.2 China Rabies Vaccine Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Rabies Vaccine Market Size by Type

9.1.1 Asia Rabies Vaccine Sales by Type (2019-2030)

9.1.2 Asia Rabies Vaccine Revenue by Type (2019-2030)

9.2 Asia Rabies Vaccine Market Size by Application

9.2.1 Asia Rabies Vaccine Sales by Application (2019-2030)

9.2.2 Asia Rabies Vaccine Revenue by Application (2019-2030)

9.3 Asia Rabies Vaccine Sales by Region

9.3.1 Asia Rabies Vaccine Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Rabies Vaccine Revenue by Region (2019-2030)

9.3.3 Asia Rabies Vaccine Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Rabies Vaccine Market Size by Type

10.1.1 Middle East, Africa and Latin America Rabies Vaccine Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Rabies Vaccine Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Rabies Vaccine Market Size by Application

10.2.1 Middle East, Africa and Latin America Rabies Vaccine Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Rabies Vaccine Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Rabies Vaccine Sales by Country

10.3.1 Middle East, Africa and Latin America Rabies Vaccine Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Rabies Vaccine Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Rabies Vaccine Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 GSK (Novartis)

11.1.1 GSK (Novartis) Company Information

11.1.2 GSK (Novartis) Overview

11.1.3 GSK (Novartis) Rabies Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 GSK (Novartis) Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 GSK (Novartis) Recent Developments

11.2 Sanofi-Pasteur

11.2.1 Sanofi-Pasteur Company Information

11.2.2 Sanofi-Pasteur Overview

11.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Sanofi-Pasteur Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Sanofi-Pasteur Recent Developments

11.3 Chengda

11.3.1 Chengda Company Information

11.3.2 Chengda Overview

11.3.3 Chengda Rabies Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Chengda Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Chengda Recent Developments

11.4 Yisheng

11.4.1 Yisheng Company Information

11.4.2 Yisheng Overview

11.4.3 Yisheng Rabies Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Yisheng Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Yisheng Recent Developments

11.5 Prcmise

11.5.1 Prcmise Company Information

11.5.2 Prcmise Overview

11.5.3 Prcmise Rabies Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Prcmise Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Prcmise Recent Developments

11.6 VACN

11.6.1 VACN Company Information

11.6.2 VACN Overview

11.6.3 VACN Rabies Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 VACN Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 VACN Recent Developments

11.7 Changsheng

11.7.1 Changsheng Company Information

11.7.2 Changsheng Overview

11.7.3 Changsheng Rabies Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Changsheng Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Changsheng Recent Developments

11.8 BCHT

11.8.1 BCHT Company Information

11.8.2 BCHT Overview

11.8.3 BCHT Rabies Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 BCHT Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 BCHT Recent Developments

11.9 Hissen

11.9.1 Hissen Company Information

11.9.2 Hissen Overview

11.9.3 Hissen Rabies Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 Hissen Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Hissen Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Rabies Vaccine Industry Chain Analysis

12.2 Rabies Vaccine Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Rabies Vaccine Production Mode & Process

12.4 Rabies Vaccine Sales and Marketing

12.4.1 Rabies Vaccine Sales Channels

12.4.2 Rabies Vaccine Distributors

12.5 Rabies Vaccine Customers

13 Market Dynamics

13.1 Rabies Vaccine Industry Trends

13.2 Rabies Vaccine Market Drivers

13.3 Rabies Vaccine Market Challenges

13.4 Rabies Vaccine Market Restraints

14 Key Findings in The Global Rabies Vaccine Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Rabies Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Vero Cell Rabies Vaccine

Table 3. Major Manufacturers of BHK

Table 4. Major Manufacturers of Chick Embryo Cell Rabies Vaccine

Table 5. Major Manufacturers of Others

Table 6. Global Rabies Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Rabies Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global Rabies Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 9. Global Rabies Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 10. Global Rabies Vaccine Revenue Market Share by Region (2019-2024)

Table 11. Global Rabies Vaccine Revenue Market Share by Region (2025-2030)

Table 12. Global Rabies Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 13. Global Rabies Vaccine Sales by Region (2019-2024) & (K Units)

Table 14. Global Rabies Vaccine Sales by Region (2025-2030) & (K Units)

Table 15. Global Rabies Vaccine Sales Market Share by Region (2019-2024)

Table 16. Global Rabies Vaccine Sales Market Share by Region (2025-2030)

Table 17. Global Rabies Vaccine Sales by Manufacturers (2019-2024) & (K Units)

Table 18. Global Rabies Vaccine Sales Share by Manufacturers (2019-2024)

Table 19. Global Rabies Vaccine Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 20. Global Rabies Vaccine Revenue Share by Manufacturers (2019-2024)

Table 21. Global Key Players of Rabies Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 22. Rabies Vaccine Price by Manufacturers 2019-2024 (USD/Unit)

Table 23. Global Rabies Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 24. Global Rabies Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Vaccine as of 2023)

Table 25. Global Key Manufacturers of Rabies Vaccine, Manufacturing Base Distribution and Headquarters

Table 26. Global Key Manufacturers of Rabies Vaccine, Product Offered and Application

Table 27. Global Key Manufacturers of Rabies Vaccine, Date of Enter into This Industry

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Rabies Vaccine Sales by Type (2019-2024) & (K Units)

Table 30. Global Rabies Vaccine Sales by Type (2025-2030) & (K Units)

Table 31. Global Rabies Vaccine Sales Share by Type (2019-2024)

Table 32. Global Rabies Vaccine Sales Share by Type (2025-2030)

Table 33. Global Rabies Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 34. Global Rabies Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 35. Global Rabies Vaccine Revenue Share by Type (2019-2024)

Table 36. Global Rabies Vaccine Revenue Share by Type (2025-2030)

Table 37. Rabies Vaccine Price by Type (2019-2024) & (USD/Unit)

Table 38. Global Rabies Vaccine Price Forecast by Type (2025-2030) & (USD/Unit)

Table 39. Global Rabies Vaccine Sales by Application (2019-2024) & (K Units)

Table 40. Global Rabies Vaccine Sales by Application (2025-2030) & (K Units)

Table 41. Global Rabies Vaccine Sales Share by Application (2019-2024)

Table 42. Global Rabies Vaccine Sales Share by Application (2025-2030)

Table 43. Global Rabies Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 44. Global Rabies Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 45. Global Rabies Vaccine Revenue Share by Application (2019-2024)

Table 46. Global Rabies Vaccine Revenue Share by Application (2025-2030)

Table 47. Rabies Vaccine Price by Application (2019-2024) & (USD/Unit)

Table 48. Global Rabies Vaccine Price Forecast by Application (2025-2030) & (USD/Unit)

Table 49. US & Canada Rabies Vaccine Sales by Type (2019-2024) & (K Units)

Table 50. US & Canada Rabies Vaccine Sales by Type (2025-2030) & (K Units)

Table 51. US & Canada Rabies Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 52. US & Canada Rabies Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 53. US & Canada Rabies Vaccine Sales by Application (2019-2024) & (K Units)

Table 54. US & Canada Rabies Vaccine Sales by Application (2025-2030) & (K Units)

Table 55. US & Canada Rabies Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 56. US & Canada Rabies Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 57. US & Canada Rabies Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 58. US & Canada Rabies Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 59. US & Canada Rabies Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 60. US & Canada Rabies Vaccine Sales by Country (2019-2024) & (K Units)

Table 61. US & Canada Rabies Vaccine Sales by Country (2025-2030) & (K Units)

Table 62. Europe Rabies Vaccine Sales by Type (2019-2024) & (K Units)

Table 63. Europe Rabies Vaccine Sales by Type (2025-2030) & (K Units)

Table 64. Europe Rabies Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 65. Europe Rabies Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 66. Europe Rabies Vaccine Sales by Application (2019-2024) & (K Units)

Table 67. Europe Rabies Vaccine Sales by Application (2025-2030) & (K Units)

Table 68. Europe Rabies Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 69. Europe Rabies Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 70. Europe Rabies Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 71. Europe Rabies Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 72. Europe Rabies Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 73. Europe Rabies Vaccine Sales by Country (2019-2024) & (K Units)

Table 74. Europe Rabies Vaccine Sales by Country (2025-2030) & (K Units)

Table 75. China Rabies Vaccine Sales by Type (2019-2024) & (K Units)

Table 76. China Rabies Vaccine Sales by Type (2025-2030) & (K Units)

Table 77. China Rabies Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 78. China Rabies Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 79. China Rabies Vaccine Sales by Application (2019-2024) & (K Units)

Table 80. China Rabies Vaccine Sales by Application (2025-2030) & (K Units)

Table 81. China Rabies Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 82. China Rabies Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 83. Asia Rabies Vaccine Sales by Type (2019-2024) & (K Units)

Table 84. Asia Rabies Vaccine Sales by Type (2025-2030) & (K Units)

Table 85. Asia Rabies Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 86. Asia Rabies Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 87. Asia Rabies Vaccine Sales by Application (2019-2024) & (K Units)

Table 88. Asia Rabies Vaccine Sales by Application (2025-2030) & (K Units)

Table 89. Asia Rabies Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 90. Asia Rabies Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 91. Asia Rabies Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 92. Asia Rabies Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 93. Asia Rabies Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 94. Asia Rabies Vaccine Sales by Region (2019-2024) & (K Units)

Table 95. Asia Rabies Vaccine Sales by Region (2025-2030) & (K Units)

Table 96. Middle East, Africa and Latin America Rabies Vaccine Sales by Type (2019-2024) & (K Units)

Table 97. Middle East, Africa and Latin America Rabies Vaccine Sales by Type (2025-2030) & (K Units)

Table 98. Middle East, Africa and Latin America Rabies Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 99. Middle East, Africa and Latin America Rabies Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 100. Middle East, Africa and Latin America Rabies Vaccine Sales by Application (2019-2024) & (K Units)

Table 101. Middle East, Africa and Latin America Rabies Vaccine Sales by Application (2025-2030) & (K Units)

Table 102. Middle East, Africa and Latin America Rabies Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 103. Middle East, Africa and Latin America Rabies Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 104. Middle East, Africa and Latin America Rabies Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 105. Middle East, Africa and Latin America Rabies Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 106. Middle East, Africa and Latin America Rabies Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 107. Middle East, Africa and Latin America Rabies Vaccine Sales by Country (2019-2024) & (K Units)

Table 108. Middle East, Africa and Latin America Rabies Vaccine Sales by Country (2025-2030) & (K Units)

Table 109. GSK (Novartis) Company Information

Table 110. GSK (Novartis) Description and Major Businesses

Table 111. GSK (Novartis) Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 112. GSK (Novartis) Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 113. GSK (Novartis) Recent Developments

Table 114. Sanofi-Pasteur Company Information

Table 115. Sanofi-Pasteur Description and Major Businesses

Table 116. Sanofi-Pasteur Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 117. Sanofi-Pasteur Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 118. Sanofi-Pasteur Recent Developments

Table 119. Chengda Company Information

Table 120. Chengda Description and Major Businesses

Table 121. Chengda Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 122. Chengda Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 123. Chengda Recent Developments

Table 124. Yisheng Company Information

Table 125. Yisheng Description and Major Businesses

Table 126. Yisheng Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 127. Yisheng Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 128. Yisheng Recent Developments

Table 129. Prcmise Company Information

Table 130. Prcmise Description and Major Businesses

Table 131. Prcmise Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 132. Prcmise Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 133. Prcmise Recent Developments

Table 134. VACN Company Information

Table 135. VACN Description and Major Businesses

Table 136. VACN Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 137. VACN Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 138. VACN Recent Developments

Table 139. Changsheng Company Information

Table 140. Changsheng Description and Major Businesses

Table 141. Changsheng Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 142. Changsheng Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 143. Changsheng Recent Developments

Table 144. BCHT Company Information

Table 145. BCHT Description and Major Businesses

Table 146. BCHT Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 147. BCHT Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 148. BCHT Recent Developments

Table 149. Hissen Company Information

Table 150. Hissen Description and Major Businesses

Table 151. Hissen Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 152. Hissen Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 153. Hissen Recent Developments

Table 154. Key Raw Materials Lists

Table 155. Raw Materials Key Suppliers Lists

Table 156. Rabies Vaccine Distributors List

Table 157. Rabies Vaccine Customers List

Table 158. Rabies Vaccine Market Trends

Table 159. Rabies Vaccine Market Drivers

Table 160. Rabies Vaccine Market Challenges

Table 161. Rabies Vaccine Market Restraints

Table 162. Research Programs/Design for This Report

Table 163. Key Data Information from Secondary Sources

Table 164. Key Data Information from Primary Sources

List of Figures

Figure 1. Rabies Vaccine Product Picture

Figure 2. Global Rabies Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Rabies Vaccine Market Share by Type in 2023 & 2030

Figure 4. Vero Cell Rabies Vaccine Product Picture

Figure 5. BHK Product Picture

Figure 6. Chick Embryo Cell Rabies Vaccine Product Picture

Figure 7. Others Product Picture

Figure 8. Global Rabies Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Rabies Vaccine Market Share by Application in 2023 & 2030

Figure 10. Pre-exposure Prophylaxis

Figure 11. Post-exposure Prophylaxis

Figure 12. Rabies Vaccine Report Years Considered

Figure 13. Global Rabies Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Rabies Vaccine Revenue 2019-2030 (US$ Million)

Figure 15. Global Rabies Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 16. Global Rabies Vaccine Revenue Market Share by Region (2019-2030)

Figure 17. Global Rabies Vaccine Sales 2019-2030 ((K Units)

Figure 18. Global Rabies Vaccine Sales Market Share by Region (2019-2030)

Figure 19. US & Canada Rabies Vaccine Sales YoY (2019-2030) & (K Units)

Figure 20. US & Canada Rabies Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 21. Europe Rabies Vaccine Sales YoY (2019-2030) & (K Units)

Figure 22. Europe Rabies Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 23. China Rabies Vaccine Sales YoY (2019-2030) & (K Units)

Figure 24. China Rabies Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Asia (excluding China) Rabies Vaccine Sales YoY (2019-2030) & (K Units)

Figure 26. Asia (excluding China) Rabies Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Middle East, Africa and Latin America Rabies Vaccine Sales YoY (2019-2030) & (K Units)

Figure 28. Middle East, Africa and Latin America Rabies Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 29. The Rabies Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 30. The Top 5 and 10 Largest Manufacturers of Rabies Vaccine in the World: Market Share by Rabies Vaccine Revenue in 2023

Figure 31. Global Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 32. Global Rabies Vaccine Sales Market Share by Type (2019-2030)

Figure 33. Global Rabies Vaccine Revenue Market Share by Type (2019-2030)

Figure 34. Global Rabies Vaccine Sales Market Share by Application (2019-2030)

Figure 35. Global Rabies Vaccine Revenue Market Share by Application (2019-2030)

Figure 36. US & Canada Rabies Vaccine Sales Market Share by Type (2019-2030)

Figure 37. US & Canada Rabies Vaccine Revenue Market Share by Type (2019-2030)

Figure 38. US & Canada Rabies Vaccine Sales Market Share by Application (2019-2030)

Figure 39. US & Canada Rabies Vaccine Revenue Market Share by Application (2019-2030)

Figure 40. US & Canada Rabies Vaccine Revenue Share by Country (2019-2030)

Figure 41. US & Canada Rabies Vaccine Sales Share by Country (2019-2030)

Figure 42. U.S. Rabies Vaccine Revenue (2019-2030) & (US$ Million)

Figure 43. Canada Rabies Vaccine Revenue (2019-2030) & (US$ Million)

Figure 44. Europe Rabies Vaccine Sales Market Share by Type (2019-2030)

Figure 45. Europe Rabies Vaccine Revenue Market Share by Type (2019-2030)

Figure 46. Europe Rabies Vaccine Sales Market Share by Application (2019-2030)

Figure 47. Europe Rabies Vaccine Revenue Market Share by Application (2019-2030)

Figure 48. Europe Rabies Vaccine Revenue Share by Country (2019-2030)

Figure 49. Europe Rabies Vaccine Sales Share by Country (2019-2030)

Figure 50. Germany Rabies Vaccine Revenue (2019-2030) & (US$ Million)

Figure 51. France Rabies Vaccine Revenue (2019-2030) & (US$ Million)

Figure 52. U.K. Rabies Vaccine Revenue (2019-2030) & (US$ Million)

Figure 53. Italy Rabies Vaccine Revenue (2019-2030) & (US$ Million)

Figure 54. Russia Rabies Vaccine Revenue (2019-2030) & (US$ Million)

Figure 55. China Rabies Vaccine Sales Market Share by Type (2019-2030)

Figure 56. China Rabies Vaccine Revenue Market Share by Type (2019-2030)

Figure 57. China Rabies Vaccine Sales Market Share by Application (2019-2030)

Figure 58. China Rabies Vaccine Revenue Market Share by Application (2019-2030)

Figure 59. Asia Rabies Vaccine Sales Market Share by Type (2019-2030)

Figure 60. Asia Rabies Vaccine Revenue Market Share by Type (2019-2030)

Figure 61. Asia Rabies Vaccine Sales Market Share by Application (2019-2030)

Figure 62. Asia Rabies Vaccine Revenue Market Share by Application (2019-2030)

Figure 63. Asia Rabies Vaccine Revenue Share by Region (2019-2030)

Figure 64. Asia Rabies Vaccine Sales Share by Region (2019-2030)

Figure 65. Japan Rabies Vaccine Revenue (2019-2030) & (US$ Million)

Figure 66. South Korea Rabies Vaccine Revenue (2019-2030) & (US$ Million)

Figure 67. China Taiwan Rabies Vaccine Revenue (2019-2030) & (US$ Million)

Figure 68. Southeast Asia Rabies Vaccine Revenue (2019-2030) & (US$ Million)

Figure 69. India Rabies Vaccine Revenue (2019-2030) & (US$ Million)

Figure 70. Middle East, Africa and Latin America Rabies Vaccine Sales Market Share by Type (2019-2030)

Figure 71. Middle East, Africa and Latin America Rabies Vaccine Revenue Market Share by Type (2019-2030)

Figure 72. Middle East, Africa and Latin America Rabies Vaccine Sales Market Share by Application (2019-2030)

Figure 73. Middle East, Africa and Latin America Rabies Vaccine Revenue Market Share by Application (2019-2030)

Figure 74. Middle East, Africa and Latin America Rabies Vaccine Revenue Share by Country (2019-2030)

Figure 75. Middle East, Africa and Latin America Rabies Vaccine Sales Share by Country (2019-2030)

Figure 76. Brazil Rabies Vaccine Revenue (2019-2030) & (US$ Million)

Figure 77. Mexico Rabies Vaccine Revenue (2019-2030) & (US$ Million)

Figure 78. Turkey Rabies Vaccine Revenue (2019-2030) & (US$ Million)

Figure 79. Israel Rabies Vaccine Revenue (2019-2030) & (US$ Million)

Figure 80. GCC Countries Rabies Vaccine Revenue (2019-2030) & (US$ Million)

Figure 81. Rabies Vaccine Value Chain

Figure 82. Rabies Vaccine Production Process

Figure 83. Channels of Distribution

Figure 84. Distributors Profiles

Figure 85. Bottom-up and Top-down Approaches for This Report

Figure 86. Data Triangulation

Figure 87. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions